CD34 and acute myeloid leukemia: First postulated by Fialkow et al. in the 1960s in CML, the concept of leukemia stem cells (LSCs) enjoyed renewed interest with the identification of a CD34+CD38− population of cells present in patients with AML that is able to recapitulate the disease in xenograft models [65,66].